Home

Wockhardt Ltd Quarterly Result

Image

Wockhardt Ltd

NSE: WOCKPHARMA

Net Profit - Last Quarter

₹ -16 Cr.

Last updated on: Jan 14, 2025

Key Highlights

  • The revenue of Wockhardt Ltd for the Sep '24 is ₹ 818 crore as compare to the Jun '24 revenue of ₹ 769 crore. This represent the growth of 6.3719115%.
  • The ebitda of Wockhardt Ltd for the Sep '24 is ₹ 119 crore as compare to the Jun '24 ebitda of ₹ 121 crore. This represent the decline of -1.6528926%.
  • The net profit of Wockhardt Ltd for the Sep '24 is ₹ -16 crore as compare to the Jun '24 net profit of ₹ -16 crore. This represent the decline of -0%.

Results Analysis

Market Price of Wockhardt Ltd

1M

1Y

3Y

5Y

Monitoring Wockhardt Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251367.6
13 Jan 20251318.4
10 Jan 20251386.95
09 Jan 20251441.15
08 Jan 20251459.5
07 Jan 20251484.65
06 Jan 20251467.25
03 Jan 20251518.6
02 Jan 20251445.75
01 Jan 20251458.55

Historical Revenue of Wockhardt Ltd

No data available

* All values are in crore

Historical EBITDA of Wockhardt Ltd

No data available

* All values are in crore

Historical Net Profit of Wockhardt Ltd

No data available

* All values are in crore

Wockhardt Ltd News Hub

Wockhardt reports consolidated net loss of Rs 14.00 crore in the June 2024 quarter

Net Loss of Wockhardt reported to Rs 14.00 crore in the quarter ended June 2024 as against net loss

Read more

2024-08-09 00:00:00

Wockhardt to table results

Wockhardt will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered by

Read more

2024-08-08 00:00:00

Wockhardt allots 8,610 equity shares under ESOS

Wockhardt has allotted 8,610 equity shares under ESOS in 26 August 2024. With this allotment, the pa

Read more

2024-08-26 00:00:00

Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections

In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has successfully

Read more

2024-09-19 00:00:00

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Feb 2024

PPT

Mar 2022

PPT

FAQs for Quarterly Results of Wockhardt Ltd

What key financial metrics are included in Wockhardt Ltd's quarterly results?

Key financial metrics in Wockhardt Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Wockhardt Ltd announce its quarterly results?

Wockhardt Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Wockhardt Ltd's quarterly performance impact its stock price?

Wockhardt Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Wockhardt Ltd's quarterly results on dividends?

The impact of Wockhardt Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Wockhardt Ltd's quarterly results?

Yes, Wockhardt Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions